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Abstract
Background and Objective: Cordyline fruticosa (Agavaceae) and Eriobotrya japonica (Rosaceae) are two medicinal plants used for the
treatment of various diseases such as infections of mammary glands, sore throat and neck pain for the first plant, diabetes, cough, ulcers,
protection against oxidative stress and cognitive deficits for the latter. The present study was designed to evaluate the antioxidant activity
of the different extracts of these two plants as well as to isolate and identify their chemical constituents. Materials and Methods: The
plant extract was prepared by maceration in methanol, compounds were isolated from EtOAc  and n-BuOH extracts of the two plants
using  column  chromatography  and  their  structures  were  determined  by  means of NMR and MS analysis as well  as  in  comparison
with  published  data.  Antioxidant  tests  (DPPH,  ferric reduction antioxidant  power  and  anti-hemolytic)  were performed over the
MeOH,  EtOAc  and  n-BuOH  extracts  of  the  plants.   Results:  The  antioxidant-guided  phytochemical  investigation  of  the MeOH
extracts  of  the  two  plants  led  to   the  isolation  of   twelve   compounds  identiWed  as:   Farrerol   1,   quercetin   helichrysoside  2,
apigenin 8-C-$-D-glucopyranoside 3, isoquercitrin 4  and  rutin  5  from  C.  fruticosa,  $-sitosterol 6,  catechin 7,  oleanolic  acid 8,
lyoniresinol 9, cinchonain IIb 10, lyoniresinol 2-a-O-$-D-xylopyranoside 11 and $-sitosterol-3-O-$-D-glucopyranoside 12 from E.  japonica.
Amongst the isolated compounds, the most important antioxidant ones were identified as helichrysoside and rutin from C.  fruticosa,
catechin, cinchonain IIb, lyoniresinol 2-a-O-$-D-xylopyranoside from E. japonica with EC50 of 8.73, 9.91, 4.11, 3.14 and 10.61 µg mLG1,
respectively. Conclusion: Based on the obtained results, it can be concluded that the high ability to scavenge free radicals, reducing power
of Fe3+ and hemolysis activity exerted by extracts of C. fruticosa and E. japonica were due to their high content of phenolic compounds,
thus the structure-activity relationships of the isolated flavonoids were discussed. The results of this study suggest that the extracts from
these two plants could serve as potential source of antioxidant compounds.
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INTRODUCTION
The presence of active  Reactive  Oxygen  Species  (ROS)
in excess of the  available antioxidant buffering capacity
defines the oxidative stress1. The oxidation of biological
molecules such as DNA, lipids and proteins can be cause by
excessive amount of ROS. Therefore, ROS are highly involved
in cellular damages and in several human diseases such as
cancer, inflammation, atherosclerosis, diabetes, hypertension,
neurodegenerative diseases, acute respiratory and pulmonary
oedema and cataracts. As such, much attention is being paid
to antioxidant substances because it is believed that they can
prevent and cure diseases or their subsequent complications
related to oxidative stress. Besides, the antioxidant capacity is
widely used as a parameter to characterize food, medicinal
plants and their bioactive components2.
The genus Cordyline with approximately 20 species
having a Southern hemisphere distribution with the greatest
diversity concentrated in Australia and New Zealand.
Cordyline  fruticosa  is a woody plants dont la graine n’a qu’un
seul cotylédon3. The plant is traditionally used for the
treatment of various diseases; the leaves are used as
haemostatic4 and to induce abortion5 and the roots are used
for toothache, laryngitis and mammary glands infections6.
Cordyline fruticosa is used in Malaysia to cure cough, bloody
cough, dysentery, fever, headache, inflammation of the
digestive tract, kidney diseases, bloody urine and also
difficulties to urinate7.
The genus Eriobotrya includes about 26 species8,9,
distributed in tropical and sub-tropical Eastern and Southern
Asia. The E.  japonica  is a well-known medicinal plant in Japan
and China and its astringent leaves have been used since long
time to treat chronic bronchitis, cough, fever and gastroenteric
disorders. A decoction of the leaves has also been applied
locally to wounds, ulcers and cancers10.  Phytochemical studies
have shown that the flowers of E.  japonica  are rich sources of
phenolic compounds and flavonoids11,12.
Currently a variety of synthetic antioxidant supplements
are marketed to balance oxidants/antioxidants but
unfortunately these substances have suspected toxic effects.
Some synthetic antioxidant such as butylated hydroxyanisole,
gallic acid esters and butylated hydroxytoluene are suspected
to have negative health effects13. Consequently, strict
restrictions on the use of these substances have been
implemented in several countries14. For these reasons,
researchers are currently focusing their attention on natural
antioxidants, particularly those obtainable from plants.
According to Cook and Samman15, the antioxidant activity of
plants is mainly due to the presence of secondary  metabolites
from the polyphenol class. In the continuous search of
potential antioxidant substances from Cameroonian medicinal
plants16-18, a bio-guided investigation was conducted for two
medicinal plants growing in the Western region of Cameroon,
namely Cordyline fruticosa  and  Eriobotrya  japonica.
MATERIALS AND METHODS
Plant materials: The leaves of Cordyline  fruticosa  (L.) A. Chev.
(Agavaceae) were collected in Dschang city (west region of
Cameroon) in December, 2011. The plant  was  identified  by
Mr. J.P. Dondjang, botanist at the Department of Forestry,
University  of    Dschang,    under   the   voucher   specimen
(Ref: LACAPE 0001) kept in our Laboratory.
The stem barks of Eriobotrya japonica (Thunb) Lindl
(Rosaceae)  were  collected  in Bafou village near Dschang
(west region of Cameroon) in March, 2013. The plant was
identified at the Cameroon National Herbarium, Yaoundé,
Cameroon by Mr. Tadjouteu Fulbert where a voucher
specimen was deposited under the reference number
44164/HCN.
Extraction and isolation
Preparation of Cordyline fruticosa  extracts: The dried and
pulverized leaves of C. fruticosa  (3 kg) were extracted three
times (each time for 24 h) with MeOH. The combined filtrate
was concentrated under reduced pressure to give a dark
residue (503 g) which was suspended in distilled water and
partitioned successively with n-hexane, EtOAc and n-BuOH,
yielding 58, 69 and 60 g of dry extracts, respectively. Part of
the EtOAc extract (59 g) was fractionated by silica gel column
chromatography using a gradient of EtOAc in n-hexane and
then a gradient of MeOH in EtOAc to give ten main fractions
(A-J). Part of the n-BuOH extract was also fractionated prior to
the purification of different fractions using silica gel column
chromatography.
Isolation  of    compounds    from   Cordyline   fruticosa:
Fraction  C  (0.5  g)  (eluted   with   Hexane-EtOAc   (6-4))  was
chromatographed on a silica gel column using hexane-EtOAc
(70-30) as eluent to mainly yield compound 1 (27 mg).
Fraction F (7.12 g)  (eluted with  EtOAc)  was  submitted  to
silica gel CC eluted with EtOAc-MeOH (98:2) and on sephadex
LH-20 CC using MeOH as eluent to give compound 2 (7 mg).
Compound 3 (57 mg) was obtained upon recrystallization
from fraction G (2.6 g) and the resulting filtrate was
chromatographed   on   silica   gel   column   eluted  with
EtOAc-MeOH-H2O (97:3:1) and then on sephadex LH-20
column (eluted with  MeOH)  to  afford  compound  4  (12 mg).
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Part of the n-BuOH extract (50 g) was fractionated by column
chromatography eluted with EtOAc containing increased
amounts of MeOH. The fraction obtained by eluting with
EtOAc-MeOH (75:25) (9.04 g) was rechromatographed on a
silica gel column using EtOAc-MeOH (90:5) as eluent to afford
six sub-fractions. One of these sub-fractions (157 mg) was
purified on a sephadex LH-20 column eluted with MeOH to
yield compound 5 (57 mg).
Preparation of Eriobotrya  japonica  extract: The dried and
ground stem bark of E. japonica (3 kg) was extracted three
times (each time for 24 h) with MeOH. The combined filtrate
was concentrated under reduced pressure to give a dark
residue (368 g), after removal of the solvent by evaporation,
part  of  this  residue  (358  g)  was  suspended  in distilled
water  and  partitioned  successively  with  n-hexane, EtOAc
and n-BuOH yielding 35.0, 38.5 and 46.5 g of dry extracts,
respectively. Part of the EtOAc extract (35 g) was absorbed
with silica gel and then fractionated on a silica gel column
using a gradient of EtOAc in n-hexane and then a gradient of
MeOH in EtOAc, affording twelve fractions (A-L).
Isolation   of    compounds    from    Eriobotrya   japonica:
Compound 6 (11 mg) was obtained upon recrystallization of
fraction C (1.4 g) (eluted with hexane-EtOAc (90:10)). Fraction
I (9.7 g) (eluted with EtOAc-MeOH  (95:5)  was  applied  on
silica gel column with EtOAc as eluent to give 3 sub-fractions
(I1, I2 and I3). Sub-fraction I1 (3.2 g) was purified on a silica gel
column   with   hexane-EtOAc   (70:30)  as    eluent   to   yield
compounds  7  (21 mg) and  8  (51 mg).   Similarly, sub-fraction
I2 (3.2 g) was subjected to silica  gel  column  eluted  with
hexane-EtOAc  (80:20)  to  yield  compound   9  (6  mg)  and
sub-fraction I3 (2.3 g) was purified  on  a  silica  gel column
using  hexane-EtOAc  (70:30) as  eluent  to  yield  compound
10 (22 mg). Fraction J (6 g) eluted with EtOAc-MeOH (90:10)
was subjected to silica gel CC eluting with EtOAc to give
compounds 11 (18 mg) and 12 (27 mg). 
Structure  elucidation   and   identification   of    the   isolated 
compounds: Samples for  NMR  experiments  were  dissolved
in  deteurated  solvents (CD3OD  and DMSO-d6)  and   analyzed
on a varian mercury plus spectrometer (400 MHz for 1H and
100 MHz for 13C). The ESI-MS were carried out on an agilent
Technologie LC/MSD Trap SL (G2445D SL). The CC was
performed on silica gel 60 (0.040-0.063 or 0.063-0.200 mm)
and sephadex gel LH-20. Fractions were monitored by TLC
using Merck pre-coated silica gel sheets (60 F254) and spots
were visualized under UV light (254 and 365 nm) and by
spraying with 50% H2SO4 and heating at 110EC.
Farrerol  1:  Yellow  powder,  13C  NMR  (CD3OD, 100 MHz)
δ 78.6 (C-2), 42.7 (C-3), 196.9 (C-4), 157.9  (C-5),  102.5  (C-6),
162.7 (C-7), 101.8 (C-8), 103.3 (C-9), 158.8 (C-10), 130.0 (C-1’),
127.4 (C-2’), 114.8 (C-3’), 157.4 (C-4’), 114.8 (C-5’), 127.4 (C-6’),
6.7   (6-Me),   5.9   (8-Me).   The   1H   NMR   (CD3OD,   400  MHz)
δ 5.30  (1H, dd,  J  =  12.9,  3.1  Hz,  H-2),  3.05  (1H,  dd,  J = 17.1,
12.9 Hz, H-3b), 2.73 (1H, dd, J = 17.1, 3.1 Hz, H-3a)  7.32 (2H, d,
J = 8.3 Hz, H-2’, 6’), 6.81 (2H, d, J = 8.8 Hz, H-3’, 5’), 1.99 (3H, s,
6-Me), 2.00 (3H, s, 8-Me).
Quercetin      3-O-[6’’trans-p-coumaroyl-$-D-
glucopyranoside]    (Helichrysoside)     2:     Yellow    powder,
13C  NMR  (CD3OD,  100  MHz)  δ  158.5   (C-2),   135.3   (C-3),
179.6 (C-4), 161.3 (C-5), 100.1 (C-6), 166.1 (C-7), 94.9 (C-8),
159.3 (C-9), 105.7 (C-10), 123.5 (C-1’), 114.9 (C-2’), 146.1 (C-3’),
149.9 (C-4’), 117.0 (C-5’), 123.2 (C-6’) for aglycone; 104.0 (C-1’’),
75.9 (C-2’’), 78.2 (C-3’’), 71.9 (C-4’’), 76.0 (C-5’’), 64.5 (C-6’’),
127.3  (C-1’’’),  131.3   (C-2’’’),   116.1   (C-3’’’),   163.1   (C-4’’’),
116.1   (C-5’’’),   131.3  (C-6’’’),   146.6   (C-7’’’),   117.4   (C-8’’’),
169.0 (C-9’’’) for sugar  moiety. The 1H  NMR  (CD3OD,  400 MHz)
δ 6.12 (1H, d, J = 1.9 Hz, H-6),  6.30  (1H,  d,  J  =  1.9  Hz, H-8),
7.58 (1H, d, J = 8.3 Hz, H-2’), 6.80 (1H,  dd,  J  =  2.4  Hz,  8.3 Hz,
H-5’),  7.56  (1H,  d,  J  =  2.4  Hz,  H-6’)  for  aglycone. About
5.26 (1H, d, J = 7.6 Hz,  H-1’’),  3.46  (1H,  m,  H-2’’),  3.44 (1H, m,
H-3’’), 3.32  (1H,  m,  H-4’’),  3.42  (1H,  m,  H-5’’),  4.29  (1H,  dd,
J = 1.8,  2.3  Hz,  H-6a),  4.18  (1H,  dd,  J = 11.8,  6.7  Hz, H-6b),
7.30  (2H,  d,  J  =  8.8  Hz,  H-2’’’,   H-6’’’)   for   sugar   moiety,
6.06 (2H, d, J = 8.8  Hz,  H-3’’’,  H-5’’’),  7.38  (1H,  d,  J  =  16.1 Hz,
H-7’’’), 6.10 (1H, d, J = 16.1 Hz, H-8’’’).
Apigenin  8-C-glucoside  3:    Yellow    powder,  13C  NMR
(DMSO-d6,  100  MHz)  δ  164.3  (C-2),  102.8(C-3),  182.5  (C-4),
161.5 (C-5), 98.5 (C-6), 163.0 (C-7), 105.0 (C-8), 156.0 (C-9),
104.2 (C-10), 122.0 (C-1’), 129.4 (C-2’), 116.2(C-3’), 160.8 (C-4‘),
116.2 (C-5’), 160.8(C-6’) for aglycone; 73.8 (C-1’’), 71.2 (C-2’’),
79.0  (C-3’’),  70.9  (C-4’’),  82.2  (C-5’’), 61.6 (C-6’’)  for sugar
moiety. The  1H NMR (DMSO-d6,  400  MHz)  δ  6.79  (1H,  s, H-3)
6.27 (1H, s, H-6), 8.03  (2H,  d,  J  =  8.3 Hz, H-2’,  6’),  6.89 (2H, d,
J = 8.6 Hz, H-3’, 5’), for aglycone; 4.69 (1H, d, J = 10.0 Hz, H-1’’),
3.84  (1H,  overlapped,  H-2’’),  3.26  (1H,  overlapped, H-3’’),
3.37 (1H, overlapped,  H-4’’),  3.24  (1H,  m,  H-5’’),  3.75  (1H, m,
H-6a’’), 3.52 (1H, m, H-6b’’) for sugar moiety.
Quercetin  3-O-$-D-glucopyranoside  4: Yellow  powder,
13C  NMR  (CD3OD,  100 MHz)    δ   157.6   (C-2),   134.2  (C-3),
178.1  (C-4),  161.1  (C-5),  98.5  (C-6),  164.7  (C-7),  93.3 (C-8),
157.6 (C-9), 104.2 (C-10), 121.7 (C-1’), 116.1 (C-2’), 144.5 (C-3’),
148.4 (C-4’), 114.6 (C-5’), 121.6 (C-6’) for aglycone; 102.8 (C-1’),
76.7 (C-2’), 77.0 (C-3’), 69.8 (C-4’),  74.3 (C-5’), 61.1(C-6’) for
sugar   moiety. The  1H   NMR  (CD3OD,  400 MHz) δ 6.20  (1H, d,
J =  2.1  Hz,  H-6),  6.39  (1H,  d,  J  =  2.1  Hz,   H-8),  7.70  (1H, d,
J = 2.2 Hz, H-2’),  6.86  (1H,  d, J  =  8.5  Hz,  H-5’),  7.58  (1H,   dd,
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J = 2.2, 8.5 Hz, H-6’) for aglycone; 5.26 (1H, d, J = 7.5 Hz, H-1’’),
3.42 (1H,  overlapped,  H-2’’),  3.21  (1H,  overlapped, H-3’’),
3.34  (1H,  overlapped,  H-4’’),  3.47  (1H,  overlapped, H-5’’),
3.70 (1H, d, J = 11.9, 2.4 Hz, H-6’’a), 3.57 (1H, d, J = 11.9, 5.3 Hz,
H-6’’b) for sugar moiety.
Quercetin     3-O-"-l-rhamnopyranosyl-(166)-$-d-
glucopyranoside (rutin) 5: Yellow powder,13C NMR (CD3OD,
100 MHz) δ 158.5 (C-2), 135.6 (C-3), 179.4 (C-4), 162.9 (C-5),
99.9 (C-6), 166.0 (C-7), 94.8 (C-8), 159.3 (C-9), 105.7 (C-10),
123.5 (C-1’), 116.0 (C-2’), 145.8 (C-3’), 149.8 (C-4’), 117.6 (C-5’),
123.1 (C-6’) for aglycone 104.7 (C-1’’), 75.7 (C-2’’), 78.1 (C-3’’),
71.3 (C-4’’), 77.2 (C-5’’), 68.5 (C-6’’), 102.4 (C-1’’’), 72.1 (C-2’’’),
72.2 (C-3’’’), 73.9 (C-4’’’), 69.7 (C-5’’’), 17.8 (C-6’’’) for sugar
moiety. The 1H NMR (CD3OD, 400 MHz) δ 6.25 (1H, d, J = 2.1 Hz,
H-6), 6.35 (1H, d, J = 2.1 Hz, H-8), 6.80 (1H, d, J = 8.5 Hz, H-2’),
7.70 (1nonoH, d, J = 2.2 Hz, H-5’), 7.65 (1H, dd, J = 8.5, 2.2 Hz,
H-6’) for aglycone.  5.15  (1H,  d,  J  =  7.6 Hz, H-1’’), 3.45 (1H, m,
H-2’’), 3.42 (1H, m, H-3’’), 3.27 (1H, m, H-4’’), 3.30 (1H, m, H-5’’),
3.40 (1H, broad single, H-6a’’), 3.80 (1H, m, H-6b’’), 4.40 (1H, d,
J  = 1.6  Hz,  H-1’’’),  3.62  (1H,  m,  H-2’’’), 3.52 (1H,  m, H-3’’’),
3.28  (1H,  m, H-4’’’), 3.45 (1H, m, H-5’’’), 1.10  (3H, d,  J = 6.2 Hz,
H-6’’’) for sugar moiety.
$-Sitosterol  6:   White   powder,  13C  (CD3OD,   100  MHz)
δ 37.3 (C-1), 31.6 (C-2),  71.8  (C-3),  42.2  (C-4),  140.8 (C-5),
121.7  (C-6),  31.9  (C-7),  31.9  (C-8),  51.2  (C-9),  36.5  (C-10),
21.1 (C-11), 39.8 (C-12), 42.3 (C-13), 56.8 (C-14), 24.3 (C-15),
28.3 (C-16), 56.0 (C-17), 11.9 (C-18), 19.4 (C-19), 36.2 (C-20),
18.8 (C-21), 33.9 (C-22), 26.1 (C-23), 45.9 (C-24), 29.2 (C-25),
19.8 (C-26), 19.3 (C-27), 23.1 (C-28), 12.2 (C-29). The  1H (CD3OD,
400 MHz) δ 3.52 (1H, m, H-3), 5.35  (1H,   brs,  H-6),  0.92 (3H, d,
J = 6.4 Hz, H-21), 0.81 (3H,  d,  J  =  6.5  Hz,  H-26),  0.83  (3H, d,
J = 6.5 Hz), 0.85 (3H, t, H-29).
Catechin  7:  Yellow  powder, 13C  NMR  (CD3OD, 100 MHz)
δ 80.0  (C-2),  67.6  (C-3),  29.4  (C-4),  157.8  (C-5),  96.5 (C-6),
158.2 (C-7), 96.0 (C-8), 146.0 (C-9), 100.2 (C-10), 132.4 (C-1’),
115.4 (C-2’), 149.5 (C-3’), 157.5 (C-4’), 116.0 (C-5’), 119.5 (C-6’).
The  1H  NMR  (CD3OD,   400   MHz):   δ   4.80   (1H,   brs,  H-2),
4.18  (1H,  m,  H-3),  2.74  (1H,  dd,  J  =   16.8,   2.8   Hz, H-4a),
2.86 (1H, dd, J = 16.8, 4.6 Hz, H-4b), 5.95 (1H, d, J = 2.3 Hz, H-6),
5.90 (1H, d, J =  2.3  Hz,  H-8),  6.97  (1H,  d,  J  =  2.0  Hz, H-2’),
6.76 (1H, d, J = 8.6 Hz, H-2’), 6.78 (1H, dd, J = 8.6, 2.0 Hz, H-6’).
Oleanolic  acid  8:   White   powder,   13C   NMR   (CD3OD,
100  MHz)  δ  38.5  (C-1),  27.4  (C-2),  78.7   (C-3),   38.7  (C-4),
55.2  (C-5),  18.3  (C-6),  36.6  (C-7),   39.8   (C-8),    47.6   (C-9),
37.0 (C-10), 23.1 (C-11), 122.1 (C-12), 143.4 (C-13), 41.6 (C-14),
27.7 (C-15), 23.4 (C-16), 46.6 (C-17), 41.3 (C-18), 45.8 (C-19),
30.6 (C-20), 33.8 (C-21), 32.3 (C-22), 28.1 (C-23), 15.6 (C-24),
15.3 (C-25), 16.8 (C-26), 26.0 (C-27), 181.0 (C-28), 33.1 (C-29),
23.6 (C-30).
Lyoniresinol 9:  White powder, 13C NMR (CD3OD, 100 MHz)
δ 33.7 (C-1),  40.9  (C-2),  66.9  (C-2a),  47.0  (C-3),  64.2 (C-3a),
42.5 (C-4), 147.7 (C-5), 139.0 (C-6), 148.7 (C-7), 107.8 (C-8),
130.3 (C-9), 126.4 (C-10), 139.4 (C-1’), 106.9 (C-2’), 149.1 (C-3’),
134.5   (C-4’),    106.9    (C-5’),    60.3    (C-6’),     56.6    (5-OMe), 
56.7 (7-OMe), 56.7 (3’, 5’-OMe). The 1H NMR  (CD3OD, 400 MHz):
δ 2.70 (1H, dd, J = 15.2, 4.9 Hz, H-1a), 2.59  (1H,  J  =  dd,  15.2,
11.4  Hz,  H-1b),  1.62  (1H,  m,   H-2),   3.49   (1H,   m,   Ha-2a),
4.59  (1H,  m,  Hb-2a),  1.95  (1H,  m,  H-3),  3.49  (2H,  m, H-3),
4.30 (1H, d, J = 5.7 Hz, H-4), 6.58 (1H, s, H-8), 6.38 (2H, s, H-2’,
6’),  3.36  (3H,  s,  5-OMe),  3.85  (3H,  s,  7-OMe),  3.73  (6H,  s, 3’,
5’-OMe).
Cinchonain  IIb  10:  Yellow  powder,  13C  NMR  (CD3OD,
100 MHz)  δ  77.1  (C-2),  73.2   (C-3),  37.1  (C-4),  156.4 (C-5),
95.5 (C-6), 151.1 (C-7), 105.5 (C-8), 153.8 (C-9), 109.1 (C-10),
133.0 (C-1’), 115.6 (C-2’), 145.8 (C-3’), 145.2 (C-4’), 116.4 (C-5’),
119.5 (C-6’), 80.5 (C-2’’), 67.6 (C-3’’), 30.1 (C-4’’), 156.2 (C-5’’),
96.5   (C-6’’),   155.7   (C-7’’),   108.9    (C-8’’),    146.2    (C-9’’),
100.2  (C-10’’),  132.8  (C-1’’’),  116.4   (C-2’’’),   145.6  (C-3’’’),
145.0   (C-4’’’),   116.0   (C-5’’’),   119.7   (C-6’’’),   136.0   (C-1’’’’),
119.5  (C-2’’’’),  145.5  (C-3’’’’),  144.3  (C-4’’’’),  115.2  (C-5’’’’),
119.8 (C-6’’’’), 37.8 (C-"), 35.3 (C-$), 171.8 (C=O). The 1H NMR
(CD3OD,  400   MHz)   δ   5.64   (1H,   H-2), 3.99  (1H,  s,  H-3),
4.65  (1H,  s,  H-4),  5.94  (1H,  s,  H-6),  6.73  (1H,   d, J  =  1.9 Hz,
H-2’), 6.68  (1H, d, m, H-5’), 6.52 (1H, dd, J  = 8.2,  2.0  Hz, H-6’),
4.33  (1H,  s,  H-2’’),  3.81  (1H,  s,  H-3”),  2.82  (1H, brs, H-4’’),
6.12 (1H, brs, H-6’’), 6.68 (1H,  m,  H-2’’’),  6.70  (1H,  m, H-5’’’),
6.62  (1H,  dd,  J  =  8.21,  2.2Hz,  H-6’’’),  6.69  (1H,  m, H-2’’’’),
6.85 (1H, brs, H-5’’’’),6.70 (1H, m, H-6’’’), 2.00 (1H, dd, J = 6.6,
15.6,  H-"1),  2.56  (1H,  dd,  J  =  6.6,  15.6,  H-"2), 4.12  (1H, dd,
J = 6.6, 15.6, H-$).
Lyoniresinol 2a-O-$-D-xylopyranoside 11: Pink powder,
13C NMR (CD3OD, 100 MHz) δ 33.9 (C-1), 40.4 (C-2), 65.9 (C-2a),
43.5 (C-3), 69.2 (C-3a), 41.6  (C-4),  146.2  (C-5), 137.0  (C-6),
147.2 (C-7), 106.3 (C-8), 128.7 (C-9), 125.6 (C-10), 138.9 (C-1’),
105.3  (C-2’, 6’),  147.5  (C-3’,  5’),  132.5  (C-4’),  58.6 (5-OMe),
55.1  (7-OMe),  55.2  (3’,  5’-OMe)  for  aglycone  103.9 (C-1’’),
73.4 (C-2’’), 76.6 (C-3’’), 69.7 (C-4’’), 65.5 (C-5’’) for sugar moiety.
The 1H NMR (CD3OD, 400 MHz) * 2.70 (1H, dd, J = 15.2, 4.9 Hz,
H-1a), 2.63 (1H, dd, J = 15.2, 11.2 Hz, H-1b), 1.70 (1H, m, H-2),
3.56 (1H, m, Ha-2a), 3.65 (1H,  m,  Hb-2a),  2.04 (1H, m, H-3),
3.84 (1H, m, Ha-3a), 3.41 (1H, m, Hb-3a), 4.37 (1H, d, J = 6.7 Hz,
H-4), 6.56 (1H, s, H-5), 6.42 (2H, s, H-2’, 6’), 3.31 (3H, s, 6-OMe),
3.85 (3H,  s,  8-OMe),  3.31  (6H,  s,  3’,  5’-OMe)  for aglycone
4.20 (1H, d, J  =  7.5  Hz,  H-1’’),  3.23  (1H,  overlapped,  H-2’’),
3.31  (1H,  overlapped,  H-3’’),  3.46  (1H,  overlapped,  H-4’’),
3.16 (1H, overlapped, H-2’’) for sugar moiety.
$-Sitosterol-3-O-$-D-glucopyranoside 12:  White  powder,
13C   (CD3OD,   100MHz)   δ   37.3   (C-1),  30.2  (C-2),   78.5   (C-3),
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39.2  (C-4),  140.8  (C-5),  121.7  (C  6),  31.9  (C-7),  31.9  (C-8),
51.2 (C-9), 36.5 (C-10),  21.1  (C-11),  39.8  (C-12),  42.3  (C-13),
56.8 (C-14), 24.3 (C-15), 28.3 (C-16), 56.0 (C-17), 11.9 (C-18),
19.4 (C-19), 36.2 (C-20), 18.8 (C-21), 33.9 (C-22), 26.1 (C-23),
45.9 (C-24), 29.2 (C-25), 19.8 (C-26), 19.3 (C-27), 23.1 (C-28),
12.2 (C-29) for aglycone, 102.5 (C-1'), 75.3 (C-2'), 78.6 (C-3'),
71.6  (C-4'),   78.1   (C-5'),   62.5   (C-6')   for  sugar   moiety.  The
1H  (CD3OD,  400   MHz)   δ   0.66-1.25  (three   CH3   groups),
3.50 (1H,  m,  H-3), 5.35 (1H, m, H-5) for aglycone; 5.02 (1H, d,
J = 7.5 Hz, H-1') representing the anomeric proton of the
sugar.
Antioxidant activity
DPPH radical scavenging test: The  antioxidant  activity  of
the extracts was determined in terms  of  hydrogen donating
or radical scavenging ability,  using  the  stable  radical DPPH
(2, 2-diphenyl-1-picrylhydrazyl), according to the procedure
described by Nguelefack-Mbuyo et al.18.
Ferric Reduction Antioxidant Power (FRAP): This experiment
was conducted as previously described by Athukorala et al.19. 
AAPH-induced Red Blood Cells (RBC) hemolysis assay: A
modified method of Zhang et al.20 was used to assess the
antihemolytic effect of extracts, fractions and compounds.
Blood samples were collected from healthy male wistar rats
through abdominal aorta into tubes containing EGTA
(Ethylene Glycol tetra acetic). The RBCs were separated from
plasma by centrifugation at 1500 rpm for10 min. The RBCs
were then washed three times with five volumes phosphate
buffer saline (PBS, pH 7.4). Thereafter, the packed RBCs were
suspended into PBS solution to obtain a 5% cell suspension.
100 µL of RBCs suspension were mixed with 100 µL solution of
extracts,  fractions,  isolated  compounds  or   ascorbic  acid.
100 µL of 200 mM 2', 2'-Azobis (2-Methylpropionamidine)
dihydrochloride (AAPH) were then added to the mixture and
incubated at 37EC for 3 h with gentle shaking. At the end of
the incubation period, 4 mL of PBS were added into the
reaction milieu  followed  by  centrifugation   at  3500 rpm for
10 min. The  absorbance  of  the  supernatant  was  read  at
540 nm. To yield a complete hemolysis, an aliquot of RBC
suspension was treated with equal volume of ice-cold distilled
water. The percentage inhibition was calculated as follow:
control sample
control
A A
I (%) = 100
A
 
Statistical analysis: All the pharmacological test data are
expressed   as    the    Mean±Standard    Error     of    the   Mean
(SEM).    About   50%    Effective    Concentrations   (EC50)  were
determined  after   logarithmic   transformation  of  the
concentration-response curve using GraphPad Prism 5.0
software. The Efficiency Index (EI) was expressed as EC50/Emax.
RESULTS AND DISCUSSION
Phytochemical  analysis:  When   the   methanol   extract   of
C.  fruticosa  and  E. japonica  were developed on the silica gel
TLC, the spots showed not only the UV absorbance at 254 or
365 nm but also a yellow colorization by spraying 10% H2SO4
solution and then heating the TLC plate, indicating the
presence of flavonoids in the extracts. 
The MeOH extracts of the leaves of C.  fruticosa  and the
stem bark of E.  japonica  were suspended into distilled H2O
and then  partitioned  successively  with  hexane,  EtOAc  and
n-BuOH to yield the hexane, EtOAc and n-BuOH extracts,
respectively. Fractionation and puriWcation of the above EtOAc
and n-BuOH extracts by column chromatography led to the
isolation of twelve compounds. The structural identification of
these compounds was carried out by interpretation of their
spectral data especially, NMR spectra in conjunction with 2D
experiments (1H-1H COSY,  HSQC, HMBC), mass spectrometry
in comparison with published information and also by co-TLC
comparison with some authentic samples previously obtained
in our research group for some cases. 
The isolated compounds (Fig. 1) were identiWed as:
farrerol  121,   quercetin   3-O-[6-trans-p-coumaroyl]-$-D-
glucopyranoside   2   (helichrysoside)22,   apigenin  8-C-$-D-
glucopyranoside  323,   quercetin    3-O-$-D   glucopyranoside
(isoquercitrin)  424  and  quercetin   3-O-"-l-rhamnopyranosyl-
(166)-ß-d-glucopyranoside  525  from  C.  fruticosa. $-sitosterol
626, catechin 714, oleanolic acid 827,  Lyoniresinol 928, cinchonain
IIb  1029,    Lyoniresinol   2-a-O-$-D-xylopyranoside   1130  and
$-sitosterol-3-O-$-D-glucopyranoside 1226 from E. japonica.
Antioxidant activity
DPPH radical scavenging test: As depicted in Fig. 2a-d crude
extracts  (MeOH  extracts)  and   their   sub-sequent   extracts
(n-BuOH and  EtOAc  extracts)  and  isolated  compounds  from
C. fruticosa and E. japonica  exhibited a good radical
scavenging activity on DPPH. It  can be noticed that the
activity  increases  with  the  fractionation  of   crude   extracts.
Eriobotrya   japonica    appeared   to   be   more   potent   than
C. fruticosa  and  compound 4 was the less active of all the
substances tested. More importantly compounds 7 and 10
isolated from E.  japonica  acted similarly to  ascorbic  acid
used as the reference drug. Indeed these compounds were as
powerful as ascorbic acid with respective efficiency index (EI)
of 0.04, 0.03 and 0.03 (Table 1). 
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Table 1: Radical scavenging activity of extracts, fractions and isolated
compounds from C. fruticosa  and E. japonica  on DPPH
Test substances EC50 (µg mLG1) Emax (%) EI
Cordyline fruticosa MeOH extract 181.30 61.86 2.93
n-BuOH extract 49.34 90.69 0.54
EtOAc extract 50.68 97.99 0.52
1 11.28 96.23 0.12
2 8.73 94.70 0.09
3 45.22 93.45 0.48
4 ND 63.83 ND
5 9.91 93.49 0.11
Eriobotrya japonica MeOH extract 16.55 93.59 0.18
EtOAc extract 7.19 94.56 0.08
7 4.11 95.25 0.04
10 3.14 94.61 0.03
11 10.61 95.11 0.11
Ascorbic acid 3.11 96.51 0.03
ND: Not determined
The antioxidant activity of   phenolic  compounds is due
to their ability to scavenge free radicals, donate hydrogen
atoms or electron or chelate metal cations. The structure of
phenolic compounds is a key determinant of their radical
scavenging and metal chelating activity and this is referred  to
as structure-activity relationships (SAR)31.
Comparing   the   structures   (Fig.   1)   and   activities  of
compounds 2, 4 and 5 (Fig. 2c), the main differences are the
substituents of the C-3 glucose moiety at position C-6''. It is
inferred that the presence of an additional p-coumaroyl
moiety (compound 2) or sugar group (compound 5) at
position C-6'' seems to have some little influence on
antioxidant activity compare to compound 4. By comparing
the  activity  of  compounds  3  and  4,   it   is   inferred   that the
Fig. 1: Chemical structures of compounds isolated from the leaves of Cordyline fruticosa  and stem bark of Eriobotrya japonica
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Fig. 2(a-d): DPPH scavenging activity of, (a) Cordyline fruticosa  extracts, (b) Eriobotrya japonica  extracts, (c) Some compounds
isolated  from  C.  fruticosa  and  (d)  Some  compounds  isolated  from E.  japonica  and reference antioxidants
(Ascorbic acid)
C-glycosylation (compound 3) or O-glycosylation and catechol
group (compound 4) are the key factor that affects the
activities, Although, compound 4 bears  a  catechol  group  in
B-ring, which is very important for radical scavenging activity
in flavonoides32 compare to compound 3, the later was more
active than the former owing  to  the  free  hydroxyl residue at
C-3 position of C-ring in compound 3 which is also a key factor
for radical scavenging activity in flavonol derivatives33-34. Thus,
the high activity of compound 10 could be attributed to its
greater number of catechol and free hydroxyl groups. 
Ferric Reduction Antioxidant Power (FRAP): The ability of
plant extracts and isolated compounds to induce the
reduction of ferric cyanide complex to the ferrous form is
associated with increase optical density. Figure 3a-d shows
that crude and sub-sequent extracts, pure isolated
compounds induced a concentration-dependent antioxidant
activity. As observed with  DPPH,  E.  japonica  was  more 
active  than  C.  fruticosa in  this  assay.  Interestingly,  the 
reducing  power  of  the EtOAc extract of E. japonica was
higher than that of ascorbic acid.
In  both   methods,    compounds    2,    7   and  10 showed
potent  activity,  while  compound  3  showed  very  weak
antioxidant  activity,  which  is  consistent  with  the reported
results.  Furthermore,  for  compound  3  and  4 quantitative
structure-activity  relationship  analysis  also  suggested that
compound  3  would   not   show   effective   activity  because
of  the  absence  of a  catechol  residue  in the B ring   and less
free-OH groups in its structure, which are required for high
antioxidant activity. Comparing the structures and activities of
compounds 1 and 7,  it is inferred that the presence of methyl
group at C-6 and C-8 seems to have little influence on the
activity.
AAPH-induced Red  Blood  Cells   (RBC)   hemolysis  assay:  All
extracts  and  isolated   compounds   potentiated  the  effect
of  AAPH  at  lower  concentrations. A  weak  antioxidant
activity was observed at a higher concentration (300 µg mLG1)
with n-BuOH, EtOAc extracts  and  compound  5  derived  from
C. fruticosa (Fig. 4a, c). The  E. japonica   failed  to  inhibit
AAPH-induced hemolysis (Fig. 4b, d).
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Fig. 3(a-d): Ferric Reducing Ability Power (FRAP) at various  concentrations  of  ascorbic  acid,  (a)  Cordyline  fruticosa  extracts,
(b) Eriobotrya japonica extracts, (c) Some compounds isolated from C. fruticosa and (d) Some compounds isolated
from E. japonica
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The SAR of Xavonoids is generally more complicated due
to the relative complexity of the Xavonoid molecules. Some of
the structural features and nature of substitutions on rings B
and C which determine the antioxidant activity of Xavonoids
include the following:
C The degree of hydroxylation and the positions of the -OH
groups in the B ring, in particular an ortho-dihydroxyl
structure of ring B (catechol group) results in higher
activity as it confers higher stability to the aroxyl radical
by electron delocalization32 or acts as the preferred
binding site for trace metals35
C A double bond between C-2 and C-3 conjugated with the
4-oxo group in C-ring enhances the radical scavenging
capacity of Xavonoids35
C A double bond between  C-2  and  C-3,  combined  with 
a 3-OH in ring C, also enhances the active radical
scavenging capacity of Xavonoids, as seen in the case of
kaempferol32. Substitution of the 3-OH results in increase
in torsion angle and loss of coplanarity and subsequently
reduced antioxidant activity36
CONCLUSION
At   the   end   of   this  study,  it  is  considered  that  the
bio-guided  purification  of  C.  fruticosa  and  E.  japonica
revealed six compounds with excellent proven antioxidant
and    scavenging    activities.     The     results     indicated    that
C.  fruticosa  and  E.  japonica  fractions exhibit excellent radical
scavenging ability in all assays employed and the EtOAc
fraction of  E.  japonica  was the most active fraction among
them. Phytochemical investigation of the fractions led to the
isolation of twelve compounds and the radical scavenging
assays indicated that all compounds have stronger antioxidant
capacity but less than the positive control ascorbic acid.
Overall,  C.  fruticosa  and  E.  japonica  are promising sources
of natural antioxidants ingredients.
It is well established that the efficacy of flavonoids as
antioxidants depend on the number and position of the
hydroxyl substitutions on the basic structure; an increase in
number of hydroxyl groups is directly correlated with
increasing activity and the 3, 4-dihydroxy substitution is
significant.
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